Selling the World
on the Vaccine Concept

Posted on 11/04/2021 at 16:30:08 MDT

Every selling system ever created by an organization starts by creating a need in the mind of the consumer for their product. One of the most classic case studies comes from an old National Biscuit Company (later called Nabisco) product. Before 1898, most consumers did not know what a soda cracker was. It was created by F.L. Sommer and Company in St. Joseph, Missouri in 1876. It was a very popular product on a very regional basis, but the company lacked the financial resources to market their product on a national scale. That changed when the company merged with several other baking companies to form the National Biscuit Company (Nabisco) in 1898. Now, they had the financial resources to market their products on an international basis.

Uneeda Biscuit

The newly-formed company hired the then famous Philadelphia advertising agency: N.W. Ayer and Son to develop a name and an effective advertising campaign for their new product. The result of their research was a product named "Uneeda Biscuit." The new product took off and before long had an international market. The ad agency was successful because they sold consumers on the idea that they needed their client's product. This simple marketing model of creating a need for a product and then supplying the product has been utilized multiple times by thousands of organizations.

This simple marketing model reached a new apex in the 1960s when the Polio Vaccine was sold to the world. The effort started when Franklin D. Roosevelt was elected president in 1932. It was leaked to the news media that he was infected by the Poliovirus. He spent much of his time as president in a wheelchair. In 1938, he personally formed the National Foundation for Infantile Paralysis, which later became the March of Dimes. Using radio personality Eddie Cantor, a radio Public Service Announcement (PSA) and a movie newsreel were created to bring awareness to the Poliovirus Epidemic. The dime became so synominous with President Roosevelt that a year after he died, the dime was recast with his picture on it.

By 1952, the media reported that Poliovirus infected 58,000 children and that 3,145 of them died from this infection. With the release of such numbers, the public insisted that their tax monies be used by their national governments to sanction the creation of a "vaccine" to not only cure this disease, but to prevent this disease from infecting other people. Previously, the work of the March of Dimes was to help people who already had the disease. The public was instead sold on the idea that of a vaccine that is designed to "prevent" the infection of a patient so that they never get sick from a disease. It is a concept which is relatively new to medicine, something not done to any major degree prior to the 20th century. When the media convinced the public of the terrors of the Polio epidemic in the middle part of the 20th century and reminded of President Roosevelt, national governments responded to "public pressure" (demand) around the world by sanctioning the scientific community to conduct experiments in an effort to find a "vaccine" that would prevent this disease from infecting people on a mass scale.

In 1955, Dr. Jonas Salk created a vaccine based upon an inactivated (killed) virus that proved successful in his lab research. However, the one most commonly used was developed by Dr. Albert Sabin using "attenuated" or weakened polio viruses. By the 1960s, the Polio Vaccine was being administered in schools all over the world. At that time, the demand was created for a Polio vaccine by a constant media barrage to the public and within a few years, a Polio vaccine was "discovered" and administered to millions of children around the world. But as the world applauded the creation of the vaccine as a major leap for mankind, we began to realize that the creation of this vaccine might have an untoward side, especially when you study the history of its main distributor.

The largest distributor of the Polio vaccine was Sanofi Pasteur, a subsidiary company of Sanofi, S.A. and more interestingly, an offshoot of the infamous Interessengemeinschaft Farbenindustrie AG (or I.G. Farben, German for "Dye Industry Syndicate Stock Corporation"), the organization that built the Nazi concentration camps and sponsored a considerable amount of untoward Nazi medical research. One example is the research of Drs. Helmuth Vetter, Friedrich Entress, and Eduard Wirths at the Auschwitz Concentration Camp. Among their many crimes, they deliberately infected their female subjects with whatever infectious disease they happened to be studying that week, so those doctors could test their experimental treatments. They had no problem testing their subjects using experimental drugs back then and from what we are seeing now, their students seem to have no problem using experimental drugs on people now.

A visit to one of many websites covering Sanofi, S.A. will show that after it was broken away from I.G. Farben in 1952, it moved to 54 Rue La Boétie, Paris, France in an effort to distance itself from its untoward Nazi German affiliations. However, their Sanofi-Pasteur division continues to produce the largest number of vaccine products of any pharmaceutical corporation. When it came to the COVID-19 virus, Sanofi-Pasteur, in an unprecedented move chose to "partner" with the infamous British company Glaxo-Smith-Kline [NYSE: GSK] (the most heavily fined pharmaceutical company in the world) to produce their COVID-19 vaccine, but they always seemed to be "behind" in their production, despite being given 2.1 billion dollars in taxpayer money on July 31, 2020! It seems that when you don't have concentration camp residents to experiment on, the research goes considerably slower.

Click Here to go to the next page!

Active Search Results